Stockscreener 앱 받기
28.65
0.45%
-0.13
시간 외 거래:
28.65
전일 마감가:
$28.78
열려 있는:
$28.66
하루 거래량:
432.25K
Relative Volume:
1.03
시가총액:
$8.41B
수익:
$20.92B
순이익/손실:
$666.06M
주가수익비율:
25.08
EPS:
1.1422
순현금흐름:
$1.85B
1주 성능:
-2.29%
1개월 성능:
+14.69%
6개월 성능:
+30.11%
1년 성능:
+38.21%
1일 변동 폭
$28.50
$28.80
1주일 범위
$28.45
$29.71
52주 변동 폭
$17.93
$30.46
프레제니우스메디칼케어 Stock (FMS) Company Profile
FMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
28.65 | 17.21B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
HCA
Hca Healthcare Inc
|
378.65 | 90.61B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
166.26 | 14.99B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.01 | 11.96B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
191.05 | 12.03B | 16.08B | 1.20B | 1.06B | 17.82 |
|
DVA
Davita Inc
|
136.33 | 10.47B | 12.82B | 936.34M | 1.47B | 10.74 |
프레제니우스메디칼케어 Stock (FMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 개시 | Berenberg | Buy |
| 2024-01-08 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-17 | 업그레이드 | Societe Generale | Hold → Buy |
| 2023-08-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 재개 | Citigroup | Neutral |
| 2023-07-12 | 개시 | Goldman | Buy |
| 2023-03-07 | 개시 | Bernstein | Mkt Perform |
| 2023-01-03 | 다운그레이드 | Jefferies | Buy → Underperform |
| 2022-10-26 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-27 | 업그레이드 | Jefferies | Underperform → Buy |
| 2022-02-11 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2021-11-23 | 개시 | HSBC Securities | Hold |
| 2021-11-11 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-20 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-06-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | 업그레이드 | UBS | Neutral → Buy |
| 2018-08-28 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2018-07-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | 업그레이드 | UBS | Sell → Neutral |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-07-08 | 업그레이드 | Jefferies | Underperform → Hold |
| 2016-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2015-08-13 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2015-07-31 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 재확인 | Feltl & Co. | Hold |
| 2013-01-14 | 업그레이드 | HSBC Securities | Neutral → Overweight |
모두보기
프레제니우스메디칼케어 주식(FMS)의 최신 뉴스
61st ERA Congress - Fresenius Medical Care
Fresenius Medical Care sets record with dividend hike By Investing.com - Investing.com India
Fresenius Medical Care sets record with dividend hike - Investing.com
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - Fresenius Medical Care
ApolloDialDb™: A Dialysis Database of the Future - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $0.07, revenue topped estimates - Investing.com
International Nurses Day 2025 - Fresenius Medical Care
Fresenius Medical Care starts 2025 with strong organic revenue and income growth - Fresenius Medical Care
Fresenius Medical Care Celebrates 40 of Dialysis Center in Sokolov, Czech Republic - Fresenius Medical Care
Fresenius Medical Care AG completes EUR 1.1 billion bond issue By Investing.com - Investing.com India
Fresenius Medical Care AG completes EUR 1.1 billion bond issue - Investing.com
Kidney transplantation and value-based care - Fresenius Medical Care
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Why Fresenius Medical Care Stock Might Be A Great Pick - Barchart.com
From Kidney Failure to Fresenius Medical Care Employee: A Transplant Story - Fresenius Medical Care
Dialysis Nurse Becomes Kidney Patient After COVID-19 - Fresenius Medical Care
What Sets Our Nurses Apart - Fresenius Medical Care
A Transplant Story: Patient Care Technician Gives Dialysis Patient the Gift of Life - Fresenius Medical Care
Fresenius Medical Care plans bond sale stabilization By Investing.com - Investing.com South Africa
The Zacks Analyst Blog Highlights Reddit, Ubiquiti And Fresenius Medical Care AG - Barchart.com
Fresenius Medical Care plans bond sale stabilization - Investing.com
Predicting Population Trends in Kidney Health Using Advanced Mathematical Modeling - Fresenius Medical Care
Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in Brazil - Fresenius Medical Care
Fresenius Economic Profit Margins Should Rise Along With Improvement in Both Operating Segments - Morningstar
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - Fresenius Medical Care
Kidney Disease: Evolving the Standard of Care - Fresenius Medical Care
Sanctuary Advisors LLC Acquires New Holdings in Fresenius Medical Care AG (NYSE:FMS) - MarketBeat
Fresenius Medical Care ADR earnings missed by $0.26, revenue fell short of estimates - Investing.com South Africa
Fresenius Medical Care published form 20-F for the fiscal year 2024 - Fresenius Medical Care
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Earnings call transcript: Fresenius Medical Care sees strong Q4 2024 growth - Investing.com
Fresenius Medical Care Q4 earnings miss estimates, stock edges higher - Investing.com
Dialysis firm FMC beats profit estimates in fourth quarter By Reuters - Investing.com
Annual Press Conference 2025 - Fresenius Medical Care
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - Fresenius Medical Care
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - Fresenius Medical Care
Growing Stronger Together: Embracing Diversity - Fresenius Medical Care
Corporate Citizenship - Fresenius Medical Care
Fresenius Medical Care: A 'Buy' Going Into 2025 (NYSE:FMS) - Seeking Alpha
Virtual reality as the next step in patient empowerment - Fresenius Medical Care
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
17,962 miles halfway around the world - Fresenius Medical Care
“How can we improve and speed up medical decisions?” - Fresenius Medical Care
20 years creating a future worth living - Fresenius Medical Care
Overcoming challenges and seizing opportunities - Fresenius Medical Care
When Maria struck — One year after the hurricane - Fresenius Medical Care
Our Way Forward - Fresenius Medical Care
Corporate Movie 2021 - Fresenius Medical Care
Our way forward - Fresenius Medical Care
The Next Level of Renal Care - Fresenius Medical Care
Me and my four kidneys - Fresenius Medical Care
프레제니우스메디칼케어 (FMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.16%
0.24%
자본화:
|
볼륨(24시간):